Publications
- A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade2023 | Second Faculty of Medicine, First Faculty of Medicine
- Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinoma2024 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?2024 | Second Faculty of Medicine, First Faculty of Medicine
- Intravesical thermochemotherapy in the treatment of high-risk and very high-risk non-muscle-invasive urothelial bladder cancer: a single-arm study2024 | Second Faculty of Medicine
- Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum2023 | Second Faculty of Medicine, First Faculty of Medicine
- T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum2022 | Second Faculty of Medicine, First Faculty of Medicine
- Re: Bladder Cancer Therapy Using a Conformationally Fluid Tumoricidal Peptide Complex Editorial Comment2022 | Second Faculty of Medicine
- Histologic tumor necrosis rate as a predictor of recurrence after surgical treatment for localized clear cell renal cell carcinoma2022 | Second Faculty of Medicine
- Interleukin-35 in idiopathic inflammatory myopathies2021 | Second Faculty of Medicine, First Faculty of Medicine
- European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel2021 | Second Faculty of Medicine, First Faculty of Medicine
Loading network view...